Pathos
AI-enabled clinical-stage biotech building a new development engine for precision oncology
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Pathos (Pathos AI) is a New York-headquartered, AI-enabled clinical-stage biotech company. It integrates AI technology, biological modeling and a large collection of oncology patient data to make clinical trials smarter and more precise, aiming to select the right patients for therapies and build a new development engine for precision oncology through multimodal data, biological modeling and biopharma partnerships. In October 2026 Pathos completed a $237 million Series E financing led by Bristol Myers Squibb.
- Website
- pathos.com
- Stage
- series-b+
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepagepathos.com
For agents
Nothing listed yet.